{"transactions":[{"id":743245,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39689,"kind":"person","name":"KLEMA CATHY","position":1,"cik":"0001181157","reported_name":"KLEMA CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T17:44:36.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":34517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":56137,"source":{"system":"sec-edgar","filing":"0001628280-26-042133","document":"wk-form4_1781113474.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181157/000162828026042133/wk-form4_1781113474.xml","form_type":"4"}},{"id":1113575,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39689,"kind":"person","name":"KLEMA CATHY","position":1,"cik":"0001181157","reported_name":"KLEMA CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:36:16.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":9868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":21620,"source":{"system":"sec-edgar","filing":"0001628280-25-031024","document":"wk-form4_1749760569.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181157/000162828025031024/wk-form4_1749760569.xml","form_type":"4"}},{"id":1285024,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39689,"kind":"person","name":"KLEMA CATHY","position":1,"cik":"0001181157","reported_name":"KLEMA CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-02-04T23:50:31.000Z","date":"2025-02-02","kind":"exercise","planned":false,"acquired":false,"shares":5109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on February 2, 2025,  the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on February 2, 2025,  the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_date":"2025-02-02","expiration_date":"2025-02-02","underlying":"Common Stock","underlying_shares":5109},"source":{"system":"sec-edgar","filing":"0001628280-25-003855","document":"wk-form4_1738713024.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1181157/000162828025003855/wk-form4_1738713024.xml","form_type":"4"}},{"id":1285023,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39689,"kind":"person","name":"KLEMA CATHY","position":1,"cik":"0001181157","reported_name":"KLEMA CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-04T23:50:31.000Z","date":"2025-02-02","kind":"exercise","planned":false,"acquired":true,"shares":5109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":11752,"source":{"system":"sec-edgar","filing":"0001628280-25-003855","document":"wk-form4_1738713024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181157/000162828025003855/wk-form4_1738713024.xml","form_type":"4"}},{"id":1483601,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39689,"kind":"person","name":"KLEMA CATHY","position":1,"cik":"0001181157","reported_name":"KLEMA CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T21:47:36.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":6643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":6643,"source":{"system":"sec-edgar","filing":"0001628280-24-027710","document":"wk-form4_1718142449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181157/000162828024027710/wk-form4_1718142449.xml","form_type":"4"}},{"id":1656900,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":39689,"kind":"person","name":"KLEMA CATHY","position":1,"cik":"0001181157","reported_name":"KLEMA CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-07T00:53:05.000Z","date":"2024-02-02","kind":"grant","planned":false,"acquired":true,"shares":5109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest in full on the first anniversary of the date of grant."}],"balance_after":5109,"derivative":{"underlying":"Common Stock","underlying_shares":5109},"source":{"system":"sec-edgar","filing":"0001628280-24-003584","document":"wk-form4_1707267174.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181157/000162828024003584/wk-form4_1707267174.xml","form_type":"4"}},{"id":3542504,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":39689,"kind":"person","name":"KLEMA CATHY","position":1,"cik":"0001181157","reported_name":"KLEMA CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2019-05-02T20:49:44.000Z","date":"2019-04-30","kind":"tax_withholding","acquired":false,"shares":953,"price":147,"value":140091.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":25081,"source":{"system":"sec-edgar","filing":"0001179110-19-005416","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181157/000117911019005416/edgar.xml","form_type":"4"}},{"id":3597312,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":39689,"kind":"person","name":"KLEMA CATHY","position":1,"cik":"0001181157","reported_name":"KLEMA CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2019-03-13T19:27:18.000Z","date":"2019-03-11","kind":"other","acquired":true,"shares":410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the liquidation of the Reporting Person's interest in a mutual fund, 410 ordinary shares of Allergan plc were distributed to the Reporting Person for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the liquidation of the Reporting Person's interest in a mutual fund, 410 ordinary shares of Allergan plc were distributed to the Reporting Person for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":26034,"source":{"system":"sec-edgar","filing":"0001179110-19-003785","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181157/000117911019003785/edgar.xml","form_type":"4"}},{"id":3945680,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":39689,"kind":"person","name":"KLEMA CATHY","position":1,"cik":"0001181157","reported_name":"KLEMA CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2018-05-04T22:20:24.000Z","date":"2018-05-02","kind":"grant","acquired":true,"shares":1985,"price":151.07,"value":299873.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units shall vest 100% on the earlier of (i) the day before the 2019 Annual General Meeting of Shareholders and (ii) May 2, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":25624,"source":{"system":"sec-edgar","filing":"0001179110-18-006355","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181157/000117911018006355/edgar.xml","form_type":"4"}},{"id":4331810,"issuer":{"id":149298,"kind":"organization","name":"Allergan plc","symbol":"AGN"},"owners":[{"id":39689,"kind":"person","name":"KLEMA CATHY","position":1,"cik":"0001181157","reported_name":"KLEMA CATHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value $0.0001","published_at":"2017-05-05T22:33:06.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":1223,"price":245.25,"value":299940.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units shall vest 100% on the earlier of (i) the day before the 2018 Annual General Meeting of Shareholders or (ii) May 4, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc."}],"balance_after":23639,"source":{"system":"sec-edgar","filing":"0001179110-17-006743","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181157/000117911017006743/edgar.xml","form_type":"4"}}]}